Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H Strauss

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Heart Failure|August 3, 2007
RAS blockers: Does sex matter? Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure - A population study: Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602-609Martin H Strauss, Alistair Hall
Lancet (London, England)|July 10, 2007
Renin-angiotensin system and cardiovascular riskMartin H Strauss, Alistair Hall
Stroke|August 1, 2009
Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: noMartin H Strauss, Alistair Hall
The Canadian Journal of Cardiology|June 9, 2005
Inhibition of the renin-angiotensin system in cardiovascular protection: Is it important to watch your C'ARB' intake?Martin H Strauss, Subodh Verma
Lancet (London, England)|February 10, 2009
Telmisartan in high-risk patients intolerant of ACE inhibitorsAlistair Hall, Martin H Strauss
Stroke|January 7, 2006
MOSES raises questionsMartin H Strauss, Subodh Verma
Progress in Cardiovascular Diseases|November 21, 2015
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and DeathMartin H Strauss, Alistair S Hall
Heart (British Cardiac Society)|August 19, 2007
More about the "ARB MI paradox"Alistair S Hall, Martin H Strauss
Circulation|August 23, 2006
Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradoxMartin H Strauss, Alistair S Hall
Circulation|June 1, 2017
Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI ParadoxMartin H Strauss, Alistair S Hall
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Heart Failure|August 3, 2007
RAS blockers: Does sex matter? Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure - A population study: Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602-609Martin H Strauss, Alistair Hall
Lancet (London, England)|July 10, 2007
Renin-angiotensin system and cardiovascular riskMartin H Strauss, Alistair Hall
Stroke|August 1, 2009
Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: noMartin H Strauss, Alistair Hall
The Canadian Journal of Cardiology|June 9, 2005
Inhibition of the renin-angiotensin system in cardiovascular protection: Is it important to watch your C'ARB' intake?Martin H Strauss, Subodh Verma
Lancet (London, England)|February 10, 2009
Telmisartan in high-risk patients intolerant of ACE inhibitorsAlistair Hall, Martin H Strauss
Stroke|January 7, 2006
MOSES raises questionsMartin H Strauss, Subodh Verma
Progress in Cardiovascular Diseases|November 21, 2015
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and DeathMartin H Strauss, Alistair S Hall
Heart (British Cardiac Society)|August 19, 2007
More about the "ARB MI paradox"Alistair S Hall, Martin H Strauss
Circulation|August 23, 2006
Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradoxMartin H Strauss, Alistair S Hall
Circulation|June 1, 2017
Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI ParadoxMartin H Strauss, Alistair S Hall
Pageof 3